ARCHIVES

As patients worry about COX-2 inhibitors, scientists and FDA review toxicity data.

This article is from The Cancer Letter archive.

Vol. 30 No. 40 | October 22, 2004

Download PDF Visit The Full Archive

Related Articles

SEER Expects To Lower Cancer Incidence Rates for Blacks by 3%

September 27, 2002

NCI Cooperative Group, Cancer Center Trials Listed

May 30, 2008

In Brief: $7 Mil. Gift allows USC To Expand Gene Therapy; North Carolina Passes Off-Label Drug Legislation

September 3, 1993

Clinical Trials Streamlining Moves Forward; NCI Commits To Full Funding For Groups

October 9, 1998

Study Finds More Deaths On Aranesp Arm In Cancer Anemia Study, No Benefit Seen.

February 2, 2007

In Brief: MD Anderson’s DuBois Named head of Arizona State’s Biodesign Institute

October 5, 2012